Italy · AIFA medicine catalogue
PRADAXA
A source-listed package record. Different packs may share the same medicine name.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 038451264
- Form
- Polvere e solvente per soluzione orale
- Composition / generic term
- DABIGATRAN ETEXILATO MESILATO
- Company as listed by source
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- Source status
- Autorizzata
- Supply classification
- Medicinali soggetti a prescrizione medica limitativa, vendibili al pubblico su prescrizione di centri ospedalieri o di specialisti
Source-listed ingredients
- DABIGATRAN ETEXILATO MESILATO
These values do not establish equivalence or a dose recommendation.
Packages
- 6,25 MG / ML - POLVERE E SOLVENTE PER SOLUZIONE ORALE - USO ORALE - POLVERE: BUSTINA (PET/ALU/LDPE), SOLVENTE: FLACONE (VETRO), POLVERE DI SUCRALOSIO: BUSTINA (PET/ALU/LDPE) , POLVERE: 180,40 MG, SOLVENTE: 28 ML, POLVERE DI SUCRALOSIO: 70 MG - 30 BUSTINE (POLVERE) + 30 CONFEZIONI PER LA PREPARAZIONE (1 FLACONE + 1 BUSTINA (POLVERE DI SUCRALOSIO) + 2 PIPETTE DOSATRICI (12 ML) + 1 ADATTATORE PER FLACONE)
Source and coverage
Open AIFA medicine catalogue →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Italy records →